- Abstract:
-
Rates of orthopaedic surgery among rheumatoid arthritis (RA) patients have been decreasing in several developed countries. One explanatory factor could be the introduction of biologic therapies. Whilst we recently tested this hypothesis using UK data, analyses that account for concurrent trends in non-RA patients is lacking. Our aim here was to estimate the impact of approval of tumour necrosis factor inhibitor therapy (TNFi) for RA on the need for total hip (THR) and total knee replacement (...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Accepted manuscript
- Publisher:
- Oxford University Press Publisher's website
- Publication date:
- 2017-04-21
- Acceptance date:
- 2016-12-16
- DOI:
- ISSN:
-
1462-0324
- Pubs id:
-
pubs:727868
- URN:
-
uri:d8529ff6-59e1-4b88-bb06-4115f54ff0c2
- UUID:
-
uuid:d8529ff6-59e1-4b88-bb06-4115f54ff0c2
- Local pid:
- pubs:727868
- Copyright holder:
- Hawley et al
- Copyright date:
- 2017
- Notes:
- © The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com This is the accepted manuscript version of the article. The final version is available online from Oxford University Press at:https://doi.org/10.1093/rheumatology/kex062.208
Conference item
Impact of biologic therapies on need for hip and knee replacement among rheumatoid arthritis and non-rheumatoid arthritis patients in Ontario, Canada: An interrupted time-series analysis
Actions
Authors
Bibliographic Details
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record